Lenore Teichert

695 total citations
15 papers, 540 citations indexed

About

Lenore Teichert is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Lenore Teichert has authored 15 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Lenore Teichert's work include Diabetes Management and Research (10 papers), Pancreatic function and diabetes (8 papers) and Diabetes Treatment and Management (7 papers). Lenore Teichert is often cited by papers focused on Diabetes Management and Research (10 papers), Pancreatic function and diabetes (8 papers) and Diabetes Treatment and Management (7 papers). Lenore Teichert collaborates with scholars based in Germany, France and United States. Lenore Teichert's co-authors include R. H. A. Becker, Irene Nowotny, Christoph Kapitza, J. Tillner, Karin Bergmann, Torsten Haack, Youssef Hijazi, Michael Wagner, Martin Bossart and Maximilian Posch and has published in prestigious journals such as Scientific Reports, Diabetologia and Diabetes Obesity and Metabolism.

In The Last Decade

Lenore Teichert

14 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lenore Teichert Germany 10 376 217 141 74 72 15 540
Renee Amori United States 5 772 2.1× 296 1.4× 306 2.2× 78 1.1× 45 0.6× 7 893
Yifei Chen China 10 305 0.8× 109 0.5× 151 1.1× 52 0.7× 27 0.4× 32 468
Kenji Kohara Japan 17 451 1.2× 308 1.4× 228 1.6× 85 1.1× 50 0.7× 53 660
Masakazu Takeuchi Japan 13 479 1.3× 128 0.6× 256 1.8× 72 1.0× 17 0.2× 29 550
Kazuhito Tawaramoto Japan 11 276 0.7× 262 1.2× 186 1.3× 62 0.8× 69 1.0× 18 479
Richard Sachson United States 6 301 0.8× 187 0.9× 92 0.7× 56 0.8× 32 0.4× 6 460
Markus Daschner Germany 9 194 0.5× 166 0.8× 173 1.2× 31 0.4× 37 0.5× 12 467
James Thrasher United States 10 469 1.2× 181 0.8× 301 2.1× 70 0.9× 33 0.5× 20 623
Christof Kazda United States 13 836 2.2× 411 1.9× 290 2.1× 175 2.4× 112 1.6× 30 1.0k
Ruben Pipek United States 8 173 0.5× 123 0.6× 214 1.5× 202 2.7× 38 0.5× 11 533

Countries citing papers authored by Lenore Teichert

Since Specialization
Citations

This map shows the geographic impact of Lenore Teichert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lenore Teichert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lenore Teichert more than expected).

Fields of papers citing papers by Lenore Teichert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lenore Teichert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lenore Teichert. The network helps show where Lenore Teichert may publish in the future.

Co-authorship network of co-authors of Lenore Teichert

This figure shows the co-authorship network connecting the top 25 collaborators of Lenore Teichert. A scholar is included among the top collaborators of Lenore Teichert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lenore Teichert. Lenore Teichert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Shah, Viral N., Amer Al‐Karadsheh, Jose Mandry, et al.. (2024). Safety and Efficacy of Switching SAR341402 Insulin Aspart and Originator Insulin Aspart vs Continuous Use of Originator Insulin Aspart in Adults With Type 1 Diabetes: The GEMELLI X Trial. Journal of Diabetes Science and Technology. 19(4). 1051–1059.
2.
Shah, Viral N., Amer Al‐Karadsheh, Jose Mandry, et al.. (2023). Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes: The GEMELLI X trial. Diabetes Obesity and Metabolism. 26(2). 540–547. 1 indexed citations
3.
Eriksson, Olof, Torsten Haack, Youssef Hijazi, et al.. (2020). Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes. Scientific Reports. 10(1). 16758–16758. 34 indexed citations
6.
Tillner, J., Maximilian Posch, Frank Wagner, et al.. (2018). A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials. Diabetes Obesity and Metabolism. 21(1). 120–128. 135 indexed citations
7.
8.
Becker, R. H. A., Irene Nowotny, Lenore Teichert, Karin Bergmann, & Christoph Kapitza. (2014). Low within‐ and between‐day variability in exposure to new insulin glargine 300 U/ml. Diabetes Obesity and Metabolism. 17(3). 261–267. 101 indexed citations
9.
Shiramoto, Masanari, Takashi Eto, S. Irie, et al.. (2014). Single‐dose new insulin glargine 300  U/ml provides prolonged, stable glycaemic control in J apanese and E uropean people with type 1 diabetes. Diabetes Obesity and Metabolism. 17(3). 254–260. 76 indexed citations
10.
Hramiak, Irene, R. H. A. Becker, Irene Nowotny, et al.. (2014). Low Within- and Between-Day Variability in Exposure to New Insulin Glargine 300 U/mL. Canadian Journal of Diabetes. 38(5). S6–S6. 4 indexed citations
11.
Becker, R. H. A., Annke Frick, Lenore Teichert, et al.. (2008). Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjects*. Diabetes Obesity and Metabolism. 10(11). 1105–1113. 14 indexed citations
12.
Becker, R. H. A., Annke Frick, Lenore Teichert, et al.. (2008). Dose–response relationship of insulin glulisine in subjects with type 1 diabetes. Diabetes Obesity and Metabolism. 11(1). 60–68. 2 indexed citations
13.
Oberwittler, Heike, Lenore Teichert, Karl‐Heinz Lehr, et al.. (2006). Significant Pharmacokinetic and Pharmacodynamic Interaction of Warfarin With the NO‐Independent sGC Activator HMR1766. The Journal of Clinical Pharmacology. 47(1). 70–77. 17 indexed citations
14.
Soergel, Marianne, et al.. (2000). Effect of ramipril on ambulatory blood pressure and albuminuria in renal hypertension. Pediatric Nephrology. 15(1-2). 113–118. 31 indexed citations
15.
Windeler, Jürgen, Hans J. Trampisch, M. Elze, et al.. (1996). Recommendations concerning Studies on Therapeutic Equivalence. Drug Information Journal. 30(1). 195–200. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026